Company Filing History:
3 out of 3 
1 out of 45 
1 out of 27 
Years Active: 2020-2024
Title: Marjolein Maria Johanna Caron: Innovator in Osteoarthritis Treatment
Introduction
Marjolein Maria Johanna Caron is a notable inventor based in Maastricht, Netherlands. She has made significant contributions to the field of medicine, particularly in the treatment and prevention of osteoarthritis. With a total of five patents to her name, her work is recognized for its innovative approach to addressing this common joint condition.
Latest Patents
One of her latest patents focuses on a method for the treatment or prevention of osteoarthritis. This invention provides means and methods for the treatment, prevention, or amelioration of osteoarthritis. More specifically, it introduces a peptide for use in the treatment, amelioration, or prevention of osteoarthritis. The peptide is characterized by being between 12 and 28 amino acids in length and comprises an amino acid sequence according to SEQ ID NO: 16 or a variant thereof. The amino acid sequence of this peptide is included in SEQ ID NO: 34 or a variant thereof.
Career Highlights
Throughout her career, Marjolein has worked with various organizations, including Chondropeptix B.V. and Universiteit Maastricht. Her experience in these institutions has allowed her to develop her innovative ideas and contribute to advancements in medical science.
Collaborations
Marjolein has collaborated with notable professionals in her field, including her coworker Tim Johannes Maria Welting. These collaborations have further enriched her research and development efforts.
Conclusion
Marjolein Maria Johanna Caron is a pioneering inventor whose work in osteoarthritis treatment showcases her dedication to improving medical outcomes. Her innovative patents and collaborations highlight her significant impact in the field of medicine.